Janus Henderson Group PLC Akero Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
176Shares Held
72MCall Options Held
178KPut Options Held
164K-
Black Rock Inc. New York, NY5.59MShares$185 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$179 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$173 Million4.29% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$169 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.15MShares$137 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.53B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...